| Humanized immunoglobulins CL Queen, WP Schneider, NF Landolfi, KL Coelingh, HE Selick US Patent 5,693,762, 1997 | 2757 | 1997 |
| A humanized antibody that binds to the interleukin 2 receptor. C Queen, WP Schneider, HE Selick, PW Payne, NF Landolfi, JF Duncan, ... Proceedings of the National Academy of Sciences 86 (24), 10029-10033, 1989 | 1431 | 1989 |
| Chimeric ligand/immunoglobulin molecules and their uses NF Landolfi US Patent 5,349,053, 1994 | 368 | 1994 |
| Interaction of cell-type-specific nuclear proteins with immunoglobulin VH promoter region sequences NF Landolfi, JD Capra, PW Tucker Nature 323 (6088), 548-551, 1986 | 295 | 1986 |
| Anti-Tac-H, a humanized antibody to the interleukin 2 receptor with new features for immunotherapy in malignant and immune disorders RP Junghans, TA Waldmann, NF Landolfi, NM Avdalovic, WP Schneider, ... Cancer Research 50 (5), 1495-1502, 1990 | 267 | 1990 |
| Humanized antibodies to γ-interferon M Vasquez, NF Landolfi, N Tsurushita, CL Queen US Patent 6,329,511, 2001 | 176 | 2001 |
| Expression of antibody Fab domains on bacteriophage surfaces. Potential use for antibody selection. CN Chang, NF Landolfi, C Queen Journal of immunology (Baltimore, Md.: 1950) 147 (10), 3610-3614, 1991 | 132 | 1991 |
| Radioimmunotherapy targeting of HER2/neu oncoprotein on ovarian tumor using lead-212-DOTA-AEl E Horak, F Hartmann, K Garmestani, C Wu, M Brechbiel, OA Gansow, ... Journal of Nuclear Medicine 38 (12), 1944-1950, 1997 | 128 | 1997 |
| Humanized immunoglobulins C Queen, W Schneider, N Landolfi, K Coelingh, H Selick US Patent App. 10/389,155, 2003 | 122 | 2003 |
| A humanized antibody specific for the platelet integrin gpIIb/IIIa. MS Co, S Yano, RK Hsu, NF Landolfi, M Vasquez, M Cole, JT Tso, ... Journal of immunology (Baltimore, Md.: 1950) 152 (6), 2968-2976, 1994 | 114 | 1994 |
| Immunoconjugates of geldanamycin and anti-HER2 monoclonal antibodies: antiproliferative activity on human breast carcinoma cell lines R Mandler, C Wu, EA Sausville, AJ Roettinger, DJ Newman, DK Ho, ... Journal of the National Cancer Institute 92 (19), 1573-1581, 2000 | 101 | 2000 |
| Activation of T lymphocytes results in an increase inH-2-encoded neuraminidase NF Landolfi, J Leone, JE Womack, RG Cook Immunogenetics 22, 159-167, 1985 | 93 | 1985 |
| A chimeric IL-2/Ig molecule possesses the functional activity of both proteins. NF Landolfi Journal of immunology (Baltimore, Md.: 1950) 146 (3), 915-919, 1991 | 91 | 1991 |
| Monoclonal antibodies specific for the platelet derived growth factor β receptor and methods of use thereof CN Chang, NF Landolfi, U Martin US Patent 5,882,644, 1999 | 81 | 1999 |
| Activated T-lymphocytes express class I molecules which are hyposialylated compared to other lymphocyte populations NF Landolfi, RG Cook molecular Immunology 23 (3), 297-309, 1986 | 69 | 1986 |
| Amphiregulin and epidermal hyperplasia: amphiregulin is required to maintain the psoriatic phenotype of human skin grafts on severe combined immunodeficient mice N Bhagavathula, KC Nerusu, GJ Fisher, G Liu, AB Thakur, L Gemmell, ... The American journal of pathology 166 (4), 1009-1016, 2005 | 59 | 2005 |
| Therapeutic use of anti-CS1 antibodies M Williams, JY Tso, NF Landolfi, DB Powers, G Liu US Patent 7,709,610, 2010 | 57 | 2010 |
| The integrity of the ball-and-socket joint between V and C domains is essential for complete activity of a humanized antibody NF Landolfi, AB Thakur, H Fu, M Vásquez, C Queen, N Tsurushita The Journal of Immunology 166 (3), 1748-1754, 2001 | 52 | 2001 |
| An antibody reactive with domain 4 of the platelet-derived growth factor β receptor allows BB binding while inhibiting proliferation by impairing receptor dimerization T Shulman, FG Sauer, RM Jackman, CN Chang, NF Landolfi Journal of Biological Chemistry 272 (28), 17400-17404, 1997 | 48 | 1997 |
| Therapeutic use of anti-CS1 antibodies M Williams, J Tso, N Landolfi US Patent App. 10/842,011, 2005 | 47 | 2005 |
